Detalles de la búsqueda
1.
Cell-specific nanoengineering strategy disrupts tolerogenic signaling from myeloid-derived suppressor cells to invigorate antitumor immunity in pancreatic cancer.
bioRxiv
; 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38854120
2.
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.
Cancer Discov
; 13(6): 1428-1453, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946782
3.
Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study.
Elife
; 112022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36107485
4.
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer.
Oncogene
; 41(28): 3640-3654, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701533
5.
Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancers.
Oncotarget
; 12(20): 2104-2110, 2021 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34611484
Resultados
1 -
5
de 5
1
Próxima >
>>